STOCKHOLDERS EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of Fair Value Measurement Inputs and Valuation Techniques

The Black-Scholes valuation model was used to estimate the fair value of the warrants with the following assumptions:

	December 31, 2024
Volatility	166.0	%
Expected term in years	2.5
Dividend rate	0.0	%
Risk-free interest rate	4.26	%

The Black-Scholes option-pricing model was used to estimate the fair value of the Series B-1 Common and Series B-2 Common Warrants with the following weighted-average assumptions:

Volatility	156.3	%
Expected term in years	1.63
Dividend rate	0.0	%
Risk-free interest rate	4.65	%

The Black-Scholes option-pricing model was used to estimate the fair value of the Series C-1 Common

Warrants, the Series C-2 Common Warrants, and the Placement Agent Warrants with the following weighted-average assumptions:

Volatility	159.1	%
Expected term in years	1.65
Dividend rate	0.0	%
Risk-free interest rate	4.92	%

The Black-Scholes option-pricing model was used to estimate the fair value of the Series D-1 Common Warrants, the Series D-2 Common Warrants, and the October 2024 PA Warrants with the following weighted-average assumptions:

Volatility	174.4	%
Expected term in years	1.65
Dividend rate	0.0	%
Risk-free interest rate	4.16	%

Schedule of Warrants Outstanding to Purchase Common Stock

As of December 31, 2024, the Company had the following warrants outstanding to purchase common stock.

Number of Shares	Exercise Price per Share	Expiration Date
210	$243.10	August 2025
9	$464,100.00	February 2026
128,577	$31.11	March 2026
44,839	$17.00	April 2026
16	$43,548.05	May 2027
1	$0.01	July 2027
3	$94,970.33	April 2028
210	$243.10	February 2029
9,002	$38.8875	June 2029
128,577	$31.11	September 2029
44,839	$17.00	October 2029
3,140	$21.25	October 2029